EUNOIA BIO TECH, LLC

Biotech · Private

Simvastatin-loaded nanoparticles using self-assembling peptide platform for sepsis and ARDS treatment

Grants
$300K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Simvastatin nanomedicine in ARDS and sepsis$299,940
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1527Element Genomics, Inc.—$4.8M
1528StabiLux Biosciences, Inc—$554K
1529PGI HOLDING CORPORATION——
1530EUNOIA BIO TECH, LLC——
1531Juno Therapeutics, Inc.—$1.0B
1532SYNAPTOGENIX, INC.——
1533Akeso——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.